TheEdgeResearch
Home / Stocks / ARI

Apollo Commercial Real Estate Finance, Inc. (ARI)

NYSE Real Estate REIT - Mortgage
$6.90 ▲ +2.68%
Market Cap
$903.5M
Sector
Real Estate
Industry
REIT - Mortgage
Beta
1.44
52-Wk Range
6.43-11.24
CEO
Stuart A. Rothstein
Country
US
Currency
USD

Apollo Commercial Real Estate Finance, Inc. operates in the REIT - Mortgage industry of the Real Estate sector, headquartered in New York City, NY, US. The stock last traded at $6.90, up 2.68% on the session, giving a market capitalisation of $903.5M. On trailing twelve-month figures it carries a trailing P/E of 8.73, a net margin of 23.3%. Its beta of 1.44 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
8.73
Price / Sales
1.59
Price / Book
0.72
EV / EBITDA
0.08
Gross margin
56.0%
Operating margin
57.5%
Net margin
23.3%
Return on equity
Debt / equity
0.30
Current ratio
0.00
Dividend yield
65.2%
Payout ratio
116.7%
Company profile
Exchange
New York Stock Exchange
Employees
0
IPO date
2009-09-24
Headquarters
New York City, NY, US
About Apollo Commercial Real Estate Finance, Inc.

Apollo Commercial Real Estate Finance, Inc. functions as a Real Estate Investment Trust (REIT) with a core focus on the U.S. market. The company specializes in originating, purchasing, maintaining, and overseeing a diverse portfolio of debt instruments related to commercial properties, including primary mortgage loans and subordinate financing structures. Having qualified as a REIT under the Internal Revenue Code, it benefits from an exemption from federal income taxes, provided it distributes a minimum of 90% of its REIT taxable earnings to its shareholders. This entity was established in 2009 and is headquartered in New York, New York.

Comparable companies

Apollo Commercial Real Estate Finance, Inc. is most often compared with the following Real Estate names:

ARRCIMDXEFCIIPRKREFLADRMFAPMTTRTX
More research on ARI
ARI technical analysis ARI TheEdge Score Compare against peers
Open full interactive analysis & DCF →